Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Adagio Medical Holdings, Inc.ADGM · Entity 7926 | Director | June 16, 2026 | August 12, 2026 |
| KESTRA MEDICAL TECHNOLOGIES, LTD.KMTS · Entity 4686 | Chief Business Officer | July 30, 2026 | August 03, 2026 |
| Motus GI Holdings, Inc.MOTS · Entity 93100 | Director | March 05, 2024 | March 13, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Adagio Medical Holdings, Inc.
Report date June 16, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-qualified stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.71 · Expires 2036-06-16 | Direct | 30,000 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 30,000 · Balance 30,000 F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
KESTRA MEDICAL TECHNOLOGIES, LTD.
Report date July 30, 2026 · Filed August 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 66,345 |
Ending reported balance
After 2026-08-03 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-07-30 · Sale · Disposed 4,117 · Balance 77,484 F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3800 to $23.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Row 2 · 2026-07-31 · Sale · Disposed 8,759 · Balance 68,725 F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F3: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1500 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Row 3 · 2026-08-03 · Sale · Disposed 2,380 · Balance 66,345 F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F4: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.5800 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units.
F2: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3800 to $23.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
F3: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1500 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
F4: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.5800 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
Motus GI Holdings, Inc.
Report date March 05, 2024 · Filed March 13, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.62 · Expires 2034-03-05 | Direct | 23,205 |
Reported balance
After 2024-03-05 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-05 · Grant · Acquired 23,205 · Balance 23,205 F1: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "Plan"). The option vests in its entirety on the first anniversary of the date of grant, March 5, 2025. The exercise price is based on the closing price for the shares of the common stock on the date of grant in accordance with the terms of the Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "Plan"). The option vests in its entirety on the first anniversary of the date of grant, March 5, 2025. The exercise price is based on the closing price for the shares of the common stock on the date of grant in accordance with the terms of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 3, 2026 23:35 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 2,380 | $23.76 | $56,551.42 |
DisclosureSEC source: 0001193125-26-331066 · ownership.xml · nonDerivative · entry 3 Moran Timothy P. · CIK 0001753958 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,345 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F4 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $23.5800 to $23.9800. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 31, 2026 Filed Aug 3, 2026 23:35 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 8,759 | $22.61 | $198,000.70 |
DisclosureSEC source: 0001193125-26-331066 · ownership.xml · nonDerivative · entry 2 Moran Timothy P. · CIK 0001753958 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,725 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F3 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.1500 to $22.9200. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 30, 2026 Filed Aug 3, 2026 23:35 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | SaleCommon Shares | 4,117 | $22.77 | $93,758.50 |
DisclosureSEC source: 0001193125-26-331066 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,484 F1 · kind: The sale reported in this Form 4 represents a nondiscretionary sale of shares required to be sold by the reporting person pursuant to sell to cover transactions to satisfy tax withholding obligations in connection with the vesting and settlement of restricted stock units. F2 · price: The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $22.3800 to $23.0400. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range. Read SEC document |
| July 16, 2026 Filed Jul 17, 2026 21:52 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | GrantCommon Shares | 39,113 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-308047 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,601 F1 · shares: Represents common shares earned with respect to an award of performance-based RSUs ("PSUs") granted on July 17, 2025, as determined based on the Issuer's achievement of specified performance goals. 100% of the PSUs vested on July 15, 2026. Read SEC document |
| June 30, 2026 Filed Jul 2, 2026 21:16 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | GrantCommon Stock | 227 | $21.55 | $4,891.85 |
DisclosureSEC source: 0001193125-26-294959 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,488 F1 · kind: Shares purchased pursuant to the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan ("ESPP") in transactions that were exempt under Rule 16b-3, for the ESPP purchase period of January 1, 2026 through June 30, 2026. F2 · price: In accordance with the ESPP, these shares were purchased at a price equal to 85% of the closing price of the Issuer's common stock on June 29, 2026. F3 · balance_after: Includes unvested RSUs. Read SEC document |
| June 16, 2026 Filed Aug 12, 2026 17:30 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | GrantNon-qualified stock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001753958-26-000002 · form4-08122026_050849.xml · derivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-16 F1 · security: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. F1 · derivative.exercise_date: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. Read SEC document |
| June 03, 2026 Filed Jun 4, 2026 22:40 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | GrantCommon Shares | 22,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-257915 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,261 F1 · shares: Represents restricted stock units ("RSU") that entitle the Reporting Person to receive, at settlement, one common share of Kestra Medical Technologies, Ltd. Subject to the Reporting Person's continued service, the RSUs will vest over three years, with 1/3 vesting on each anniversary of June 3, 2026. Read SEC document |
| December 03, 2025 Filed Dec 5, 2025 02:48 UTC | KESTRA MEDICAL TECHNOLOGIES, LTD. KMTS · Entity 4686 | GrantCommon Shares | 19,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-308424 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Chief Business Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,557 F1 · shares: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest in three ratable installments on each of November 3, 2026, November 3, 2027 and November 3,2028, subject to the Reporting Person's continued service through such date. F1 · price: The reported securities represent restricted stock units ("RSUs") which each entitle the Reporting Person to receive one common share of the Issuer. The RSUs will vest in three ratable installments on each of November 3, 2026, November 3, 2027 and November 3,2028, subject to the Reporting Person's continued service through such date. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 22:58 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | GrantNon-qualified stock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001415889-25-008802 · form4-03212025_100303.xml · derivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2034-07-31 F1 · security: Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024. F1 · derivative.exercise_date: Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024. Read SEC document |
| March 05, 2024 Filed Mar 13, 2024 01:27 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantStock Option (right to buy) · Derivative | 23,205 | $0.00 Strike: $0.62 | $0.00 |
DisclosureSEC source: 0001493152-24-009745 · ownership.xml · derivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,205 Underlying: Common Stock, par value $0.0001 per share · 23,205 shares Expires 2034-03-05 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "Plan"). The option vests in its entirety on the first anniversary of the date of grant, March 5, 2025. The exercise price is based on the closing price for the shares of the common stock on the date of grant in accordance with the terms of the Plan. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 22:11 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantStock Option (right to buy) · Derivative | 175,000 | $0.00 Strike: $0.46 | $0.00 |
DisclosureSEC source: 0001493152-22-004067 · ownership.xml · derivative · entry 2 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock, par value $0.0001 per share · 175,000 shares Expires 2032-02-10 F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2016 Plan. The option vests in a series of twelve (12) successive substantially equal quarterly installments, with the first installment vesting on May 1, 2022 and continuing the first day of each third month thereafter. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. Read SEC document |
| February 10, 2022 Filed Feb 11, 2022 22:11 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantCommon Stock, par value $0.0001 per share | 175,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-22-004067 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 657,701 F1 · shares: On February 10, 2022, Reporting Person was granted 175,000 Common Stock restricted stock units. The restricted stock units vest in a series of twelve (12) successive substantially equal quarterly installments, with the first installment vesting on May 1, 2022 and continuing the first day of each third month thereafter. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). Read SEC document |
| November 19, 2021 Filed Nov 22, 2021 13:01 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | PurchaseCommon Stock, par value $0.0001 per share | 10,000 | $0.52 | $5,214.00 |
DisclosureSEC source: 0001213900-21-061012 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 482,701 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.5203 to $0.5224, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 21:15 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantStock Option (right to buy) · Derivative | 141,000 | $0.00 Strike: $1.78 | $0.00 |
DisclosureSEC source: 0001213900-21-010581 · ownership.xml · derivative · entry 2 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,000 Underlying: Common Stock, par value $0.0001 per share · 141,000 shares Expires 2031-02-17 F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2016 Plan. The option vests in substantially equal quarterly installments over three years commencing from the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. Read SEC document |
| February 17, 2021 Filed Feb 19, 2021 21:15 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantCommon Stock, par value $0.0001 per share | 141,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-21-010581 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 472,701 F1 · shares: On February 17, 2021, Reporting Person was granted 141,000 Common Stock restricted stock units. The restricted stock units vest in substantially equal quarterly installments over three years commencing on February 17, 2021. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). Read SEC document |
| December 04, 2020 Filed Dec 7, 2020 14:01 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | PurchaseCommon Stock, par value $0.0001 per share | 10,000 | $0.96 | $9,644.00 |
DisclosureSEC source: 0001213900-20-041229 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,701 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9634 to $0.9653, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 11, 2020 Filed Nov 13, 2020 22:33 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantStock Option (right to buy) · Derivative | 190,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0001213900-20-037013 · ownership.xml · derivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 190,000 Underlying: Common Stock, par value $0.0001 per share · 190,000 shares Expires 2030-11-11 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 20:31 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0001213900-20-014839 · ownership.xml · derivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock, par value $0.0001 per share · 200,000 shares Expires 2030-06-11 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). One-hundred percent (100%) of the shares subject to the option vest on the first anniversary of the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:35 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantStock Option (right to buy) · Derivative | 103,720 | $0.00 Strike: $2.16 | $0.00 |
DisclosureSEC source: 0001213900-20-002929 · ownership.xml · derivative · entry 2 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 103,720 Underlying: Common Stock, par value $0.0001 per share · 103,720 shares Expires 2030-02-06 F2 · derivative.exercise_date: The option award was made in accordance with the terms of the 2016 Plan. The option vests in substantially equal quarterly installments over three years commencing from the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. Read SEC document |
| February 06, 2020 Filed Feb 7, 2020 21:35 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantCommon Stock, par value $0.0001 per share | 103,720 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-002929 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,701 F1 · shares: On February 6, 2020, Reporting Person was granted 103,720 Common Stock restricted stock units. The restricted stock units vest in substantially equal quarterly installments over three years commencing on February 6, 2020. Each restricted stock unit represents a contingent right to receive one share of Common Stock. The restricted stock units award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). Read SEC document |
| November 20, 2019 Filed Nov 20, 2019 21:30 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | PurchaseCommon Stock, par value $0.0001 per share | 10,000 | $1.54 | $15,400.00 |
DisclosureSEC source: 0001213900-19-024215 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,981 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.53 to $1.58, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 01, 2019 Filed Jul 1, 2019 20:10 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | PurchaseCommon Stock, par value $0.0001 per share | 3,333 | $3.00 | $9,999.00 |
DisclosureSEC source: 0001213900-19-011867 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,981 F1 · kind: The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on July 1, 2019. Read SEC document |
| May 22, 2019 Filed May 24, 2019 11:02 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | PurchaseCommon Stock, par value $0.0001 per share | 5,000 | $3.38 | $16,900.00 |
DisclosureSEC source: 0001615774-19-008371 · s118506_form4.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,648 Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 22:02 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantStock Option (right to buy) · Derivative | 28,944 | $0.00 Strike: $4.30 | $0.00 |
DisclosureSEC source: 0001615774-19-002645 · s116123_form4.xml · derivative · entry 2 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,944 Underlying: Common Stock, par value $0.0001 per share · 28,944 shares Expires 2029-02-13 F2 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). The option vests in substantially equal quarterly installments over three years commencing from the date of grant. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. Read SEC document |
| February 13, 2019 Filed Feb 15, 2019 22:02 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantCommon Stock, par value $0.0001 per share | 174,648 | $0.00 | $0.00 |
DisclosureSEC source: 0001615774-19-002645 · s116123_form4.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 199,648 F1 · shares: On February 13, 2019, the Reporting Person was granted 174,648 Common Stock restricted stock units. 165,000 of the restricted stock units vest in substantially equal quarterly installments over four years commencing on October 1, 2018. 9,648 of the restricted stock units vest in substantially equal quarterly installments over four years commencing on February 13, 2019. Each restricted stock unit represents a contingent right to receive one share of Common Stock. Read SEC document |
| December 24, 2018 Filed Dec 26, 2018 22:08 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | PurchaseCommon Stock, par value $0.0001 per share | 10,000 | $2.70 | $27,000.00 |
DisclosureSEC source: 0001615774-18-014977 · s114870_form4.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 F1 · kind: The securities were purchased pursuant to an underwritten public offering by the Issuer. The offering closed on December 24, 2018. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 15:12 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | PurchaseCommon Stock, par value $0.0001 per share | 15,000 | $3.48 | $52,200.00 |
DisclosureSEC source: 0001615774-18-013097 · ownership.xml · nonDerivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.39 to $3.63, inclusive. Reporting Person undertakes to provide to Motus GI Holdings, Inc., any security holder of Motus GI Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 08, 2018 Filed Nov 9, 2018 21:30 UTC | Motus GI Holdings, Inc. MOTS · Entity 93100 | GrantStock Option (right to buy) · Derivative | 495,000 | $0.00 Strike: $3.78 | $0.00 |
DisclosureSEC source: 0001615774-18-012429 · ownership.xml · derivative · entry 1 Moran Timothy P. · CIK 0001753958 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 495,000 Underlying: Common Stock · 495,000 shares Expires 2028-11-08 F1 · derivative.exercise_date: The option award was made in accordance with the terms of the Issuer's 2016 Equity Incentive Plan (the "2016 Plan"). The option vests in twelve equal quarterly installments beginning on January 1, 2019 and continuing on the first day of each third month thereafter. The exercise price is based on the closing price for the shares of the Common Stock on the date of grant in accordance with the terms of the 2016 Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.